(Q38500352)
Statements
1 reference
Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial (English)
1 reference
Helinä Hakko
1 reference
Pirkko Räsänen
1 reference
Evgueni Tchoukhine
1 reference
Pirjo Takala
1 reference
Mirjam Raidma
1 reference
Hanna Putkonen
1 reference
Viacheslav Terevnikov
1 reference
Jan-Henry Stenberg
1 reference
Markku Eronen
1 reference
24 August 2010
1 reference
1 reference
72
1 reference
3
1 reference
326-330
1 reference
Identifiers
1 reference
1 reference